Cureatr has raised a Series B round totaling $13 million in a move to support expanded partnerships with DaVita HealthCare Partners and to further its national expansion, according to a company statement.
The company provides a secure messaging tool to help healthcare professionals collaborate and discuss a patient’s condition.
Healthcare technology private equity firm Deerfield Investments led the financing round, and Cerner Capital, Windham Ventures, also contributed. Returning investors participating in the Series B included Cardinal Partners, Milestone Venture Partners, Partnership Fund for New York City, and JMI Services.
Tackling Rising Drug Costs and Growing Popularity of GLP-1’s
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
In March, Cureatr expanded its collaboration with the company across its outpatient dialysis centers and its managed care business Healthcare Partners widening its users to thousands of clinicians. At the time of the deal Cureatr CEO and co-founder Dr Joseph Mayer said DaVita has forced it to accelerate its technology.
Mayer said in a company statement on the fundraise: “In order to accomplish this expansion, we are working to launch networks in key new markets this year with regional and technology partners to support our users’ population management needs. We’re using our mobile care coordination platform to fit into the workflow to each of our users, which traditionally has not been possible with in-network EMRs, and has been mostly unexplored by other population health technologies.”